Large-scale testing (Phase 3)Study completedNCT02678312
What this trial is testing
Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of LCZ696 Followed by a 52-week, Double-blind Study of LCZ696 Compared With Enalapril in Pediatric Patients With Heart Failure
Who this might be right for
Pediatric Heart Failure
Novartis Pharmaceuticals 393